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Abstract
Background
One-year mortality after hip-fracture is a widely used outcome measure when comparing
hospital care performance. However, traditional analyses do not explicitly consider the
referral of patients to municipality care after just a few days of hospitalization. Furthermore,
traditional analyses investigates hospital (or municipality) variation in patient outcomes
in isolation rather than as a component of the underlying patient variation. We therefore
aimed to extend the traditional approach to simultaneously estimate both case-mix adjusted
hospital and municipality comparisons in order to disentangle the amount of the total patient
variation in clinical outcomes that was attributable to the hospital and municipality level,
respectively.
Methods
We determined 1-year mortality risk in patients aged 65 or above with hip fractures regis-
tered in Sweden between 2011 and 2014. We performed cross-classified multilevel analysis
with 54,999 patients nested within 54 hospitals and 290 municipalities. We adjusted for indi-
vidual demographic, socioeconomic and clinical characteristics. To quantify the size of the
hospital and municipality variation we calculated the variance partition coefficient (VPC) and
the area under the receiver operator characteristic curve (AUC).
Results
The overall 1-year mortality rate was 25.1%. The case-mix adjusted rates varied from
21.7% to 26.5% for the 54 hospitals, and from 18.9% to 29.5% for the 290 municipalities.
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The VPC was just 0.2% for the hospital and just 0.1% for the municipality level. Patient
sociodemographic and clinical characteristics were strong predictors of 1-year mortality
(AUC = 0.716), but adding the hospital and municipality levels in the cross-classified model
had a minor influence (AUC = 0.718).
Conclusions
Overall in Sweden, one-year mortality after hip-fracture is rather high. However, only a
minor part of the patient variation is explained by the hospital and municipality levels. There-
fore, a possible intervention should be nation-wide rather than directed to specific hospitals
or municipalities.
Introduction
Increasing demands for healthcare fueled by aging populations, increasing prevalence of mul-
timorbid patients and technological advances combined with restricted financial resources
constitute a major challenge for health care systems globally [1]. To address this challenging
task many countries have started to streamline their healthcare systems by improving care and
reducing length of stay in hospitals, which includes earlier discharge to care in community set-
tings or at home with professional support (i.e., homecare) [2, 3]. Hip fracture care is an exam-
ple of this development where surgery is performed at the hospital while postoperative
rehabilitation and further care of potential sequelae are done in the primary health care sector.
Therefore, evaluating the quality of care after hip fracture needs to simultaneously consider
both the hospital and the municipality settings. When evaluating quality of care after hip frac-
ture, one-year mortality is frequently used as an outcome quality indicator in many healthcare
systems [4]. From this perspective, identifying unwarranted variability between not only hos-
pitals but also municipalities has considerable health policy relevance [5–7].
It is well-established that multilevel modelling is a suitable methodology when comparing
different types of cluster (e.g., hospital, municipalities) for both statistical and conceptual rea-
sons [8–18]. However, existing multilevel model studies evaluating healthcare performance
after hip fracture have primarily focused on hospital level variation [12, 19–22]. Less work has
been carried out analysing the potential variability among municipalities [23]. Cross-classified
multilevel analysis allows us to decompose the total individual level variation into its hospital
and its municipality level components [24, 25]. To our knowledge no previous studies have
applied measures of components of variance and of discriminatory accuracy to examine indi-
vidual variation in one-year mortality with respect to both hospitals and municipalities. There-
fore, we use cross-classified multilevel analysis to evaluate one-year mortality in all patients
suffering from hip fracture in Sweden.
Population and methods
Databases and study population
This historical follow-up study was based on prospectively collected data available from medi-
cal registries in Sweden (about 9.3 million inhabitants by 2010) with free access to medical
care. At birth or upon immigration, all citizens in Sweden are assigned a unique registration
number through which all contact with the healthcare system is recorded. This allows unam-
biguous record linkage between registries.
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We obtained information on diagnoses, medication use and mortality from the Swedish
Patient Register, the Swedish Prescribed Drug Register [26], and from the Cause of Death Reg-
ister [27] administered by the National Board of Health and Welfare. We obtained demo-
graphic and socioeconomic information from the Population Register [28] and the
Longitudinal Integration Database for Health Insurance and Labour Market Studies (LISA)
register (http://www.scb.se/lisa), which are administrated by Statistics Sweden. To ensure the
anonymity of the subjects, the Swedish authorities transformed the personal identification
numbers of the individuals into arbitrary numbers before delivering the research databases to
us, and we linked the databases using the anonymized identification number.
We defined hip fracture as the presence of any discharge diagnosis with a fracture of the
femur coded according the International Classification of Diseases, 10th revision (ICD codes)
as fracture of the femoral neck (S72.0), pertrochanteric (S72.1) or subtrochanteric (S72.2).
From the Swedish Patient Registry, we identified all 56,161 patients being 65 years or older
and residing in Sweden by 31th December 2010 who were discharged from the Swedish hospi-
tals between 2011 and 2014 with a diagnosis of hip (i.e., femoral) fracture and surgery code.
Next, we excluded 1,162 patients because they were residing less than five years in Sweden
(n = 173), they have missing information on education (n = 976) or erroneous information on
death date (n = 2). We also excluded 11 patients treated at facilities with less than 10 hip frac-
ture patients during the study period (Fig 1). Patients which previous hip fracture compose of
11.95% (6,575/48,424) of our population.
Ethics and data accessibility
The Regional Ethics Review Board in southern Sweden (Dnr: 2014/856) as well as the data
safety committees from the National Board of Health and Welfare and from Statistics Sweden
approved the construction of the database used in this study.
The database we analysed is not publicly available for ethical and data safety reasons. How-
ever, the same dataset can be constructed by request to the Swedish National Board of Health
and Welfare and Statistics Sweden after approval of the research project by an Ethical Commit-
tee and by the data safety committees of the Swedish Authorities. The study also needs to be
performed in collaboration with Swedish researchers. [29]
Assessment of variables
Mortality. For each patient we ascertained all-cause mortality within one year from the
admission date to hospital.
Sociodemographic and clinical characteristics of the patients. Part of the initial differ-
ences between hospitals or municipalities may relate to differences in case mix. To make the
observational measurement of hospital and municipality effects as valid as possible we there-
fore adjusted for potential differences in patient sociodemographic and clinical characteristics
as well as use of medication (Table 1).
Sociodemographic characteristics. We use the age of the individuals in years as a continu-
ous variable and included it in the analysis as a quadratic function. We categorized the patients
as immigrants if they were born in another country and as natives if they were born in Sweden.
We calculated household individualized disposable income by dividing the total disposable
income of the family of the patient by the number of family members, considering the different
consumption weights of adults and children, according to Statistics Sweden (http://www.scb.
se/lisa). We did so for the complete Swedish population in three occasions 2010, 2005 and
2000, and summarized the three occasion by computing the cumulative income. Finally, using
the tertile values of the cumulative income distribution we divided the study population into
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high, medium and low income. In this form, we categorized each patient according his/her
income category in the total population rather than the population of patients.
We classified education achievement as compulsory schooling of nine years or less, second-
ary education three years or less, and higher education. We defined low education achieve-
ment as compulsory school or less and use the value of the member of the family with the
highest educational achievement for all member in the same family.
For defining those patients living alone, we first identified all patients who were cohabiting.
That is, married couple, in a registered partnership or in an unregistered partnership with a
common child as well as those living in a household with at least another adult. We group all
other patients into the living alone category.
We combined sociodemographic characteristics into a single sociodemographic risk score
for all-cause mortality. We did this via a logistic regression analysis modelling all-cause mortal-
ity as a function of age, gender, income, cohabiting, born in Sweden and education (see S1
Table). The individual predicted probabilities were then categorized into four groups by quar-
tiles as low, medium, high, and very high. The low-risk score group was then used as the refer-
ence in the comparisons in the subsequent multilevel analyses.
Fig 1. Flowchart patient inclusion.
https://doi.org/10.1371/journal.pone.0234041.g001
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Clinical characteristics. For the purpose of patient-mix adjustment and using previous
knowledge on risk factors for mortality in patients with hip fractures [30, 31] as well as consid-
ering the variables included in the Charlson comorbidity index (CCI), we selected a number of
diseases (ICD-10 codes) identified during the five years before hospital admission (see S2
Table). We then applied logistic regression to obtain a clinical risk score (i.e., individual pre-
dicted probability) of one-year mortality based on the following variables: Chronic kidney dis-
ease (N18), Acute myocardial infarction (I21), Heart failure (I50), Other peripheral vascular
diseases (I73), Cerebrovascular diseases (I60-I69), Atherosclerosis- Aortic aneurysm and dis-
section (I70-I71), Dementia (F01-F03), Chronic lower respiratory diseases (J40-J47), Other
disorders of the skin and subcutaneous tissue (L80-L99), Peptic ulcer (K27), Diseases of liver
Table 1. Characteristic of the hip fracture population. Values are percentages (number of patients) if not otherwise
indicated.
Overall 1-year mortality 25.08
Number of patients in the population 54,999
Number of hospitals 54
Number of municipalities 290
Median number of patients at the hospital (min–max) 1015.50 (158–3,724)
Median number of patients at the municipality (min–max) 189.65 (15–4,687)
Age group (years)
• 65–74 18.38 (10,108)
• 75–84 42.29 (23,258)
• > 85 39.33 (21,633)
Gender
• Men 30.87 (16,976)
• Women 69.13 (38,023)
Biomedical risk score for all-cause mortality
• Low 38.42 (21,132)
• Medium 11.94 (6,566)
• High 24.81 (13,645)
• Very high 24.83 (13,656)
Education
• Low education 85.31 (46,922)
• High education 14.69 (8,077)
Income
• Low 35.87 (19,728)
• Medium 41.33 (22,731)
• High 22.80 (12,540)
Migration status
• Immigrant 7.94 (4,365)
• Native (reference) 92.06 (50,634)
Cohabiting status
• Living alone (reference) 64.76 (35,620)
• Living together 35.24 (19,379)
Medication
• Bisphosphonates 0.63 (346)
• Analgesics 27.07 (14,886)
• Psycholeptics 59.90 (32,942)
• Psychoanaleptics 43.53 (23,939)
https://doi.org/10.1371/journal.pone.0234041.t001
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(K70-K77), Diabetes mellitus (E08-E13), Hemiplegia (G81), Neoplasms (C00-D49), Human
Immunodeficiency Virus (HIV) (B20), osteoporosis (M80-M81), previous Hip fracture
(S70-S72). Finally, we created four categories of clinical risk scores using the quartile values of
the risk score distribution and considering the group with the lowest risk score as reference in
the comparisons.
Use of medication. Using the Anatomical Therapeutic Chemical (ATC) classification
from the Swedish Prescribed Drug Register we also obtained information on previous use of
Analgesics (ATC cod: N02), Psycholeptics (N05), Psychoanaleptics (N06) and Bisphospho-
nates (M05BA) as these medications may influence the vital prognosis of the patients [32, 33].
Statistical analysis
We applied single-level (conventaional) and multilevel logistic regression analyses of discrimi-
natory accuracy as decribed elsewhere [18]. We developed three consecutive logistic regression
analyses to model one-year mortality.
The first model (model 1) is a single-level logistic regression including the socioeconomic
risk score in four groups. This model aimed to evaluate the influence of patients’ demographi-
cal characteristic on one-year mortality.
The second (model 2) is also a single-level logistic regression that expands model 1 to
include the risk score for clinical factors as well as use of medication.
In the final, third model (model 3), we expanded model 2 by adding two random effects,
one for the hospital level and the other for municipality level. In this way the model was con-
verted into a two-way cross-classified multilevel model with the patients nested within the 54
hospitals and the 290 municipalities. As described elsewhere [18], we calculated the hospital
and municipality general contextual effects as expressed by the variance partition coefficient
(VPC) which informs on the share of the total individual variance in the propensity of one-
year mortality that is at the hospital (VPCH) and at the municipality level (VPCM).
For all models, we calculated the Area Under the receiving operator characteristics Curve
(AUC) or C-statistics [34] as a measure of discriminatory accuracy. Hosmer and Lemeshow
[35] suggest that an AUC of 0.70 to 0.80 could be considered as ’acceptable’, 0.80 to 0.90 as
’excellent’ and 0.90 or above as ’outstanding’, while an area under the ROC curve of 0.50 sug-
gests no discrimination between the outcome groups (i.e., similar as tossing a coin to decide
group membership). In model 3 we separately calculated the AUC when adding the random
effect for the hospital (AUCH) and the random effect for the municipality (AUCH). Then, we
calculated the increment in the AUC [18] when going from model 1 to model 2 (AUCΔ2−1)
and from model 2 to model 3 (AUCΔ3−2). The increment in AUC measures the improvement
in the ability of the model to correctly classify individuals with or without the outcome (i.e.,
one-year mortality) when considering the hospital or the municipality of the patients. The
AUC provides analogous information as the VPC [24] as both measures inform on the general
contextual effect of the hospital and of the municipality levels in relation to the patients’ one-
year mortality. As it has been explained elsewhere [12, 13, 18, 36–41] the general contextual
effect, expresses the relevance of the hospital/municipality context for understanding patients’
differences in one-year mortality.
In model 3 we use the predicted hospital and municipality random effects (shrunken resid-
uals) to obtain case-mix adjusted and reliability-weighted average mortality rates and their
95% credible intervals and created league tables illustrating the ranking of the hospitals and of
the municipalities.
In the supplementary material S1 File we provided an extended explanation of the
methodology.
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Results
Characteristics of the hip fracture population
The Swedish cohort of hip fracture patients consists of 54,999 patients. The unadjusted popula-
tion one-year mortality was 25.1%. The hip fracture patients were mainly women, and most of
the patients were living alone. Table 1 describes the additional characteristics of the
population.
Patient effects
High sociodemographic scores and high clinical scores were strong predictors for one-year
mortality (Table 2). The AUC1 in model 1, which informs on the discriminatory accuracy of
the sociodemographic information, had a value of 0.667 (95% CI: 0.662–0.672). Including the
clinical score of the patients and use of medicines increased the AUC to 0.716 (95% CI: 0.711–
0.720) (model 2). The use of analgesics, psycholeptics or psychoanaleptics was associated with
Table 2. Analysis of 1-year mortality after hip fracture in the Swedish hospitals.
Simple logistic regression analysis Cross classified multilevel logistic
regression analysis
Model 1 Model 2 Model 3
Specific individual average effects
Sociodemographic RS
•Low 1.00 1.00 1.00
•Medium 1.88 (1.75–2.01) 1.74 (1.62–1.86) 1.71 (1.59–1.82)
•High 2.99 (2.80–3.19) 2.72 (2.55–2.91) 2.68 (2.52–2.84)
•Very high 5.68 (5.33–6.04) 5.34 (5.01–5.69) 5.29 (4.98–5.57)
Clinical RS
•Low 1.00 1.00
•Medium 1.18 (1.10–1.27) 1.17 (1.08–1.25)
•High 1.54 (1.45–1.62) 1.53 (1.45–1.61)
•Very high 2.67 (2.53–2.81) 2.66 (2.52–2.80)
Medication
Bisphosphonates 0.91 (0.69–1.19) 0.91 (0.67–1.17)
Analgesics 1.14 (1.08–1.20) 1.13 (1.07–1.19)
Psycholeptics 1.26 (1.20–1.32) 1.26 (1.20–1.32)
Psychoanaleptics 1.32 (1.26–1.38) 1.32 (1.27–1.37)
General contextual effects
Hospital variance 0.007 (0.002–0.013)
Municipality variance 0.002 (0.001–0.005)
VPCH hospital 0.2
VPCM municipality 0.1
AUC 0.667 (0.662–0.672) 0.716 (0.711–0.720) 0.718 (0.713–0.722)
AUCΔ2−1 (increment model 2- model 1) Reference 0.049
AUCΔ3−2 (increment model 3- model 2) Reference 0.002
RS = Risk score for all-cause mortality, VPC = Variance Partition Coefficient, AUC = Area under the receiver operating characteristic curve
1) Model 1: Simple logistic regression model including the socioeconomic risk score for all-cause mortality
2) Model 2: Simple logistic regression model including the socioeconomic and biomedical risk scores for all-cause mortality
3) Model 3: Cross-classified multilevel logistic regression model including the socioeconomic and biomedical risk scores for all-cause mortality and the hospitals and
municipalities as random effects.
https://doi.org/10.1371/journal.pone.0234041.t002
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an increased risk of one-year mortality (Table 2). However, use of bisphosphonates was not
associated with one-year mortality.
Hospital effects
In the period from 2011 to 2014, 54 hospitals treating patients with hip fracture were included
in our study. These hospitals treated between 158 and 3,724 patients. The hospital unadjusted
one-year mortality expressed as percentage varied between 19.6% and 29.8%. The league table
obtained from the multilevel analysis shows that after adjustment for patient case-mix and
municipality effects the hospital mortality rates extended from 21.7% to 26.5% (Fig 2). The
general contextual effect of the hospital on the patients’ risk for one-year mortality was, how-
ever, low as only 0.2% of the adjusted individual variation in one-year mortality laid at the hos-
pital level. Also, the increase in the discriminative accuracy when adding the hospital level to
the model including only patient level variables was only 0.002 units (model 2).
Municipality effects
After admission the hip fracture patients were discharged to 290 different municipalities in
Sweden. The number of hip fracture patients in each municipality varied from 15 to 4,687 hip
Fig 2. League table ranking the 54 hospitals according to their adjusted absolute risk of 1-year mortality with 95% confidence intervals obtained
from the cross-classified multilevel model.
https://doi.org/10.1371/journal.pone.0234041.g002
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fracture patients in the three years. The unadjusted mortality rate expressed as percentage var-
ies between 7.1% and 37.9%. After adjustment for the difference in case-mix, and the hospital
effects in the multilevel analysis the municipality differences in one-year mortality extended
between 18.9% and 29.5% (Fig 3). The general contextual effect of the municipalities on the
patients’ risk for one-year mortality was also low as only 0.1% of the total individual variance
in the propensity of dying was at the municipality level. Also, the increase in the discriminative
accuracy when adding the municipality level to the model including only patient level variables
was only 0.002 units (model 2).
Discussion
In this nationwide population-based study of Swedish hip fracture patients, the crude one-year
mortality rate was 25.1% during the period 2011–2014. Patient sociodemographic and clinical
characteristics were predictors of one-year mortality (AUC = 0.718), whereas the cross-classi-
fied multilevel analysis revealed that the AUC of the regressions model including hospitals and
municipality as random effects was only marginally higher compared to the single-level
model. Accordingly, hospital and municipality level variation corresponded to less than 1% of
the overall individual variation in the underlying propensity of death within one year.
Fig 3. League table ranking the 290 municipalities according to their adjusted absolute risk of 1-year mortality with 95% confidence intervals
obtained from the cross-classified multilevel model.
https://doi.org/10.1371/journal.pone.0234041.g003
PLOS ONE Hospital and municipality variation for understanding one-year mortality risk after hip fracture
PLOS ONE | https://doi.org/10.1371/journal.pone.0234041 June 3, 2020 9 / 14
For evaluating the performance of the hospital and municipality health care performance
we considered two measures, the overall unadjusted one-year mortality rate after hip fracture
and the size of the general contextual effects. In our study the overall unadjusted one-year
mortality rate of 25.08% is comparable to a previous Danish register study, which in the period
2011 to 2014 reported a one-year mortality of 26% [42]. However, our mortality rate was
higher than that found in a previous study on seven European countries, which found a mor-
tality rate of 22.3% in Sweden in 2007 [43]. In this European study the lowest mortality, 19%,
was observed in Italy. Those differences might be explained by differences in study design and
changing comorbidity patterns across time as well as country differences in healthcare provi-
sion [42, 44].
After adjustment for patient case-mix, the size of the general context effect is assumed to
inform on the influence of the hospital and municipality health care levels on the vital progno-
sis of the patients [24]. The VPCs we found in this study were small, being 0.1% for municipal-
ities and 0.2% for hospitals. Meaning that once we have adjusted for patient characteristics,
patients treated at the same hospital or at the same municipality have very little in common
according to their propensity of death within one year. That is, there were very small differ-
ences between hospitals and between municipalities (se elsewhere for an extended explanation
on this concept [24])
To our knowledge no previous studies have applied cross-classified multilevel analyses to
hip fracture data and so a direct comparison is therefore not possible. However, our results are
in line with a previous Danish multilevel study examining hospital variation in 30-day mortal-
ity among hip fracture patient (but ignoring municipality variation), which found a VPC for
hospitals of 0.9%.
The AUC of the cross-classified multilevel analysis was slightly higher compared to the sin-
gle-level model, which still indicated that the cross-classified multilevel analysis was a better
model than the single-level model even though the VPC was low for both the hospital and the
municipality levels. However, the AUCs of the models were overall moderate, ranging from
0.667 to 0.718.
In our study bisphosphonates were not associated with reduced mortality. In randomized
controlled trials, use of bisphosphonates have been shown to be effective for preventing both
osteoporotic fractures [45–47] and mortality after hip fracture [48]. The protective effect of
bisphosphonates on mortality after hip fracture has also been observed in numerous observa-
tional studies. However, recent research has suggested that the reduction in mortality occurs
within the first weeks after treatment and, therefore, could express confounding [33].
Our study was strengthened by the cross-classified multilevel study design, as well as by the
nationwide population-based coverage with complete follow-up on one-year mortality due to
linkage to Swedish registries. However, our study only analysed the Swedish hospitals and
municipalities and, therefore, cannot be generalized to other country contexts.
The treatment, care and rehabilitation of hip fracture patients at both hospitals and munici-
palities are fundamentally important. We found that hospital and mortality differences in aver-
age mortality risks were only a minor share of the total individual variance in the propensity to
die or that, in other words, adding the hospital and municipality level does not increase the dis-
criminatory accuracy obtained by patient level information only. This means that the hospital
and municipality performances are homogenous overall in the country. Therefore, our results
indicate that we will not lower mortality after hip fracture in Sweden by focusing on specific
hospitals or specific municipalities with high average mortality. Rather, special efforts to
reduce mortality after hip fracture should be focused on vulnerable patient groups of hip frac-
ture patients wherever they are. From this reason, however, hospitals and municipalities with a
higher number of vulnerable patients than other will need more intense interventions. Future
PLOS ONE Hospital and municipality variation for understanding one-year mortality risk after hip fracture
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multilevel studies among hip fracture patients need to investigate differences in provided care
and intermediate outcomes such as complications [49].
In conclusion, using cross-classified multilevel regression analysis, we observed that overall
in Sweden, one-year mortality after hip-fracture at 25.1% was rather high during the period
2011–2014. We also observed that the average one-year adjusted mortality varied between
21.7% and 26.5% for hospitals and between 18.9% and 29.5% for municipalities. However,
while the patient socioeconomic and clinical characteristics appears relevant for predicting
mortality, only a minor part of the patient variation was explained by the hospital and munici-
pality levels. Therefore, future interventions should focus on identifying high risk patient
groups and be nationwide rather than directed at specific hospital or municipalities.
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